A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan

Clinical trial NCT01876745 · COMPLETED

Trial details

NCT number: NCT01876745
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Glanzmann's Disease

Start date: 2014-10-07
Primary completion: 2017-06-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.